CMS Backs Off Negotiated Price Rules for Part D, Medicare Advantage Drugs

Drug Industry Daily
A A
The Centers for Medicare and Medicaid Services has backed off a proposed rule that would have used the lowest possible payment to a pharmacy as the baseline price for Medicare.

To View This Article:

Login

Subscribe To Drug Industry Daily